{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:40:04Z","timestamp":1790613604592,"version":"4.1.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9,1]]},"DOI":"10.1210\/jc.2007-0746","type":"journal-article","created":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T03:38:35Z","timestamp":1182310715000},"page":"3470-3475","source":"Crossref","is-referenced-by-count":115,"title":["Long-Term Administration of Testosterone Undecanoate Every 3 Months for Testosterone Supplementation in Female-to-Male Transsexuals"],"prefix":"10.1210","volume":"92","author":[{"given":"Andreas","family":"Mueller","sequence":"first","affiliation":[{"name":"Departments of Obstetrics and Gynecology (A.M., H.B., M.W.B., R.D.), Erlangen University Hospital, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Kiesewetter","sequence":"additional","affiliation":[{"name":"Department of Dermatology (F.K.), Erlangen University Hospital, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Binder","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology (A.M., H.B., M.W.B., R.D.), Erlangen University Hospital, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias W.","family":"Beckmann","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology (A.M., H.B., M.W.B., R.D.), Erlangen University Hospital, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Dittrich","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology (A.M., H.B., M.W.B., R.D.), Erlangen University Hospital, D-91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113512584000_R1","first-page":"291","article-title":"Endocrine treatment of male and female transsexualism","author":"Hamburger","year":"1969","journal-title":"In: Green R, Money J, eds. Transsexualism and sex reassignment. Baltimore, MD: Johns Hopkins Press;"},{"key":"key\n\t\t\t\t2019041113512584000_R2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3999(98)00085-3","article-title":"Transsexualism: a review of etiology, diagnosis and treatment.","volume":"46","author":"Cohen-Kettenis","year":"1999","journal-title":"J Psychosom Res"},{"key":"key\n\t\t\t\t2019041113512584000_R3","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2002-021967","article-title":"Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.","volume":"88","author":"Moore","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"key\n\t\t\t\t2019041113512584000_R4","first-page":"31","article-title":"Hormone treatment of the adult transsexual patient","volume":"64","author":"Gooren","year":"2005","journal-title":"Horm Res"},{"key":"key\n\t\t\t\t2019041113512584000_R5","first-page":"1260","article-title":"Endocrine management of transsexual: hormonal profiles of serum prolactin, testosterone, and estradiol.","volume":"80","author":"Futterweit","year":"1980","journal-title":"NY State J Med"},{"key":"key\n\t\t\t\t2019041113512584000_R6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1210\/jcem-66-2-444","article-title":"Estrogen-induced prolactinoma in a man.","volume":"66","author":"Gooren","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113512584000_R7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0026-0495(89)90233-3","article-title":"Mortality and morbidity in transsexual patients with cross-gender hormone treatment.","volume":"38","author":"Asscheman","year":"1989","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113512584000_R8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones.","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113512584000_R9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/eje.0.1450365","article-title":"A psycho-endocrinological overview of transsexualism.","volume":"145","author":"Michel","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113512584000_R10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2265.2003.01821.x","article-title":"Endocrine intervention for transsexuals.","volume":"59","author":"Levy","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113512584000_R11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000094097","article-title":"Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient.","volume":"62","author":"Dizon","year":"2006","journal-title":"Gynecol Obstet Invest"},{"key":"key\n\t\t\t\t2019041113512584000_R12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1745-7262.2006.00204.x","article-title":"Testosterone decreases adiponectin levels in female to male transsexuals.","volume":"8","author":"Berra","year":"2006","journal-title":"Asian J Androl"},{"key":"key\n\t\t\t\t2019041113512584000_R13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/eje.1.02192","article-title":"The effects of sex-steroid administration on the pituitary-thyroid axis in transsexuals.","volume":"155","author":"Bisschop","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113512584000_R14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1369\/jhc.6A6928.2006","article-title":"Effects of long-term androgen administration on breast tissue of female-to-male transsexuals.","volume":"54","author":"Slagter","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"key\n\t\t\t\t2019041113512584000_R15","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1373\/clinchem.2006.067041","article-title":"Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals.","volume":"52","author":"Slagter","year":"2006","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041113512584000_R16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-0029-1211479","article-title":"Multistep treatment concept of transsexual patients.","volume":"104","author":"Schlatterer","year":"1996","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key\n\t\t\t\t2019041113512584000_R17","first-page":"623","article-title":"Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.","volume":"74","author":"Meikle","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113512584000_R18","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/jcem-51-6-1335","article-title":"Treatment of male hypogonadism with testosterone enanthate.","volume":"51","author":"Snyder","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113512584000_R19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1018638715498","article-title":"Endocrine therapy of transsexualism and potential complications of long-term treatment.","volume":"27","author":"Futterweit","year":"1998","journal-title":"Arch Sex Behav"},{"key":"key\n\t\t\t\t2019041113512584000_R20","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1517\/14656566.6.10.1751","article-title":"Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism.","volume":"6","author":"Harle","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"key\n\t\t\t\t2019041113512584000_R21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13685530601063689","article-title":"Clinical experience with the new long-acting injectable testosterone undecanoate. Report on the educational symposium on the occasion of the 5th World Congress on the Aging Male, 9\u201312 February 2006, Salzburg, Austria.","volume":"9","author":"Morales","year":"2006","journal-title":"Aging Male"},{"key":"key\n\t\t\t\t2019041113512584000_R22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00345-006-0120-0","article-title":"Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido).","volume":"24","author":"Yassin","year":"2006","journal-title":"World J Urol"},{"key":"key\n\t\t\t\t2019041113512584000_R23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.1.01943","article-title":"High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone.","volume":"153","author":"Mueller","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113512584000_R24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2006-925198","article-title":"Effects on the male endocrine system of long-term treatment with gonadotropin-releasing hormone agonists and estrogens in male-to-female transsexuals.","volume":"38","author":"Mueller","year":"2006","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113512584000_R25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-2005-865900","article-title":"Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.","volume":"113","author":"Dittrich","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key\n\t\t\t\t2019041113512584000_R26","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum.","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113512584000_R27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1365-2265.1999.00881.x","article-title":"Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.","volume":"51","author":"Nieschlag","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113512584000_R28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/j.1939-4640.2002.tb02249.x","article-title":"Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study.","volume":"23","author":"von Eckardstein","year":"2002","journal-title":"J Androl"},{"key":"key\n\t\t\t\t2019041113512584000_R29","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1210\/jc.2004-0897","article-title":"Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism.","volume":"89","author":"Schubert","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113512584000_R30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","article-title":"Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects.","volume":"58","author":"Elbers","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113512584000_R31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem-62-1-16","article-title":"Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals.","volume":"62","author":"Futterweit","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113512584000_R32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement.","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113512584000_R33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2006-924062","article-title":"Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.","volume":"114","author":"Mueller","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key\n\t\t\t\t2019041113512584000_R34","first-page":"403","article-title":"The role of albumin in the calculation of free and bioavailable testosterone in women with hyperandrogenemia.","volume":"20","author":"Mueller","year":"2006","journal-title":"In Vivo"},{"key":"key\n\t\t\t\t2019041113512584000_R35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2265.1998.00396.x","article-title":"Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones.","volume":"48","author":"van Kesteren","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113512584000_R36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2004.02125.x","article-title":"Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects.","volume":"61","author":"Turner","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113512584000_R37","first-page":"2227","article-title":"The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals.","volume":"81","author":"van Kesteren","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113512584000_R38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-0029-1211999","article-title":"Transsexualism and osteoporosis.","volume":"106","author":"Schlatterer","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key\n\t\t\t\t2019041113512584000_R39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1677\/joe.0.1800107","article-title":"Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals.","volume":"180","author":"Giltay","year":"2004","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t2019041113512584000_R40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01542220","article-title":"Physical and hormonal evaluation of transsexual patients: a longitudinal study.","volume":"15","author":"Meyer 3rd","year":"1986","journal-title":"Arch Sex Behav"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/9\/3470\/10404430\/jcem3470.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T05:01:07Z","timestamp":1707973267000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/9\/3470\/2597579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-0746","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}